Načítá se...
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
BACKGROUND: Although endometrial adenocarcinoma is a common gynaecological cancer, a comparatively small proportion of patients present with, or develop, recurrent or advanced disease. However, for those women whose disease does progress or recur the prognosis is poor and the best treatment is yet t...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2012
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7104534/ https://ncbi.nlm.nih.gov/pubmed/22895938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003915.pub4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|